Nuvalent shares surge 39% after UK's GSK agrees to buy the drugmaker for $10.6 billion

Jun 9, 2026 - 06:10
 0  0
Nuvalent shares surge 39% after UK's GSK agrees to buy the drugmaker for $10.6 billion
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0